TL033 TFA is a component of an antibody-drug conjugate (drug-linker conjugate for ADC). It comprises a linker and a bioactive small molecule toxin. TL033 TFA can be conjugated with the antibody Sacituzumab (anti-Trop-2) to synthesize BT001021, which exhibits anticancer activity against various cancers, including breast cancer, non-small cell lung cancer (NSCLC), and gastric cancer.
Molecular Weight:
1744.86
CAS Number:
[2746343-70-2]
Formula:
C78H104F3N13O25S2
Target:
Drug-Linker Conjugates for ADC
T212019
* VAT and and shipping costs not included. Errors and price changes excepted
